Company
United StatesDevalingam Mahalingam, M.D., Ph.D., Chicago, IL – FDA Inspections
Inspection records and compliance data for Devalingam Mahalingam, M.D., Ph.D. in Chicago, Illinois. 1 FDA inspection on record (1 OAI), 1 warning letter, last inspected October 18, 2024.
Company Profile
This profile covers Devalingam Mahalingam, M.D., Ph.D. based in Chicago, Illinois, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 1
- VAI
- 0
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 1
Inspected October 18, 2024.
Most cited issue areas
- FD-1572, protocol compliance1 inspection
- Short form: Oral presentation/signing1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 18, 2024 | OAI | Human Drugs · Bioresearch Monitoring | 1252477 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Devalingam Mahalingam, M.D., Ph.D.
Address
676 N Saint Clair St Ste 1200, Chicago, Illinois 60611, United States
Country
United States
ID: c4aa9219-b3c2-4842-a24f-cd02d1b4c5ad